Lorena Cros joins Optimus3D to collaborate in the development of customized solutions in surgery

Lorena Cros is the new addition to Optimus3d. After finishing her medical degree, she completed a master’s degree in Biomedical Engineering and dedicated himself to research and technology development. At Optimus3d, she completed my master’s internship, where she designed, based on the segmentation of medical images, an endovascular stent prototype for the treatment of complex…

Basque Health Cluster and Novo Nordisk start a strategic partnership to boost the health sector in the Basque Country

Derio, 4 December 2024 – The Basque Health Cluster and Novo Nordisk have recently signed a partnership agreement, whereby the Danish company becomes the first Business Partner of the Basque cluster. This agreement not only strengthens the shared commitment of both organizations towards innovation and collaboration, but also marks a strategic milestone in the consolidation…

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities

San Sebastian, Spain, December 4, 2024 — VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in the life sciences and healthcare sectors. The partnership with Ampersand will enable the expansion of VIVEbiotech’s lentiviral vector manufacturing and…

Asistentes a la reunión de seguimiento del proyecto Osasun KM0 celebrada el 8 de octubre en las instalaciones de Mizar

Biolan continues to work on the Osasun Km0 project, an initiative that advocates for a local and effective health ecosystem in the Basque Country

On the 8th of November, Tuesday, BIOLAN participated in the monitoring meeting of the OSASUN KM0 partnership. During this meeting, the progress of the project and the necessary steps to create and establish a KM0 ecosystem for the health sector in the Basque Country were discussed. After the COVID-19 pandemic, it has become evident that…

Our partner Naru wins the Startup Creasphere award from Roche Farma Spain.

Step Oncology, the technological tool developed by the Guipuzkoa-based company (partially funded by the SPRI Group through a Venture Capital Society), has received the highest award in the hepatocarcinoma category. This edition of Startup Creasphere saw the participation of a total of 56 startups from Spain and various European countries. The Guipuzkoa-based company Naru and…